Correction: Long COVID clinical evaluation, research and impact on society: a global expert consensus.

IF 3.6 2区医学 Q1 MICROBIOLOGY

Annals of Clinical Microbiology and Antimicrobials Pub Date : 2025-07-10 DOI:10.1186/s12941-025-00803-w

Andrew G Ewing, David Joffe, Svetlana Blitshteyn, Anna E S Brooks, Julien Wist, Yaneer Bar-Yam, Stephane Bilodeau, Jennifer Curtin, Rae Duncan, Mark Faghy, Leo Galland, Etheresia Pretorius, Spela Salamon, Danilo Buonsenso, Claire Hastie, Binita Kane, M Asad Khan, Amos Lal, Dennis Lau, Raina MacIntyre, Sammie McFarland, Daniel Munblit, Jeremy Nicholson, Hanna M Ollila, David Putrino, Alberto Rosario, Timothy Tan

引用次数: 0

查看原文本刊更多论文

更正：长期临床评估、研究和对社会的影响：全球专家共识。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Annals of Clinical Microbiology and Antimicrobials MICROBIOLOGY-

CiteScore

8.60

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： Annals of Clinical Microbiology and Antimicrobials considers good quality, novel and international research of more than regional relevance. Research must include epidemiological and/or clinical information about isolates, and the journal covers the clinical microbiology of bacteria, viruses and fungi, as well as antimicrobial treatment of infectious diseases. Annals of Clinical Microbiology and Antimicrobials is an open access, peer-reviewed journal focusing on information concerning clinical microbiology, infectious diseases and antimicrobials. The management of infectious disease is dependent on correct diagnosis and appropriate antimicrobial treatment, and with this in mind, the journal aims to improve the communication between laboratory and clinical science in the field of clinical microbiology and antimicrobial treatment. Furthermore, the journal has no restrictions on space or access; this ensures that the journal can reach the widest possible audience.